Company: CNTB
Filing Date: 2025-06-10
Form Type: S-8
Source: 0001193125-25-138485
Chunk: 3

Company: Connect Biopharma Holdings Ltd
Filing Date: 2025-06-10
Form: S-8
Chunk 3
---
 costs, charges, expenses, losses, damages or liabilities incurred or sustained by such directors or officer, other than by reason of such person’s dishonesty, willful default or fraud, in or about the conduct of the
Registrant’s business or affairs (including as a result of any mistake of judgment) or in the execution or discharge of his or her duties, powers, authorities or discretions, including without prejudice to the generality of the foregoing, any
costs, expenses, losses or liabilities incurred by such director or officer in defending (whether successfully or otherwise) any civil proceedings concerning the Registrant or its affairs in any court whether in the Cayman Islands or elsewhere. This
standard of conduct is generally the same as permitted under the Delaware General Corporation Law for a Delaware corporation.

In addition, the Registrant has entered into indemnification agreements with its directors and specific executive officers
that provide such persons with additional indemnification beyond that provided in the Charter.

Insofar as indemnification
for liabilities arising under the Securities Act may be permitted to the Registrant’s directors, officers or persons controlling the Registrant under the foregoing provisions, the Registrant has been informed that in the opinion of the
Commission, such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable.

Item 7. Exemption from Registration Claimed.

Not applicable.

Item 8. Exhibits.

|         |     |                                                                                                                                   |     | Incorporation by Reference |     |            |     |           |     |             |     |           |
| Exhibit 
 No.     |     | Description                                                                                                                       |     | Form                       |     | File No.   |     |   Exhibit 
 Reference |     | Filing Date |     | Filed or  
 Furnished 
 Herewith  |
| 4.1     |     | Fifth Amended and Restated Memorandum                                                                                             
 of Association of Connect Biopharma Holdings Limited                                                                              |     | 20-F                       |     | 001-40212  |     |       1.1 |     | 3/31/2022   |     |           |
| 4.2     |     | Specimen Certificate for Ordinary                                                                                                 
 Shares                                                                                                                            |     | F-1/A                      |     | 333-253631 |     |       4.1 |     | 3/12/2021   |     |           |
| 4.3     |     | Deposit Agreement, among Connect